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S U M M A R Y
Objective: The identiﬁcation of patients colonized or infected with carbapenemase-producing
Enterobacteriaceae (CPE), in order to control and prevent the global spread of multidrug-resistant
(MDR) pathogens.
Methods: From June 1 to June 15, 2012, eight Citrobacter freundii strains with reduced susceptibility to
carbapenems were isolated from rectal swabs of hospitalized patients during active screening following
the detection of a Klebsiella pneumoniae carbapenemase (KPC) -positive patient on the ward. All isolates
were analyzed phenotypically and molecularly by PCR and sequencing. Genotype clustering was
performed by multilocus sequence typing (MLST) analysis.
Results: The isolates showed high rates of multidrug resistance proﬁle. A phenotypic assay for
carbapenemase production suggested the presence of metallo-b-lactamase (MBL). The blaVIM-1 gene
was detected in all imipenem-resistant C. freundii isolates. MLST showed that the C. freundii isolates
shared the same sequence type (ST). Phylogenetic analysis revealed a strict relationship with an ST5 C.
freundii isolate from a diarrhea patient in China.
Conclusions: Our ﬁndings showed that the active surveillance program for CPE was useful, not only for
the detection of KPC-producers, but also to identify and control the spread of other MDR pathogens that
could expand the spectrum of circulating MDR pathogens.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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In recent years, the emergence and the very rapid spread of
Enterobacteriaceae carrying carbapenem-hydrolyzing lacta-
mases (carbapenemases) have been observed throughout the
world, representing a serious threat to public health due to the
great limitations of antimicrobial therapy.1 Recently, several
outbreaks of plasmid-acquired carbapenemase-producing
Enterobacteriaceae (CPE) have been reported in Europe,
suggesting an intense circulation of these microorganisms  in
this area.1 Among the different types of carbapenemases,
class A klebsiella pneumoniae  carbapenemase (KPC) and
class B (Verona integron-encoded metallo-b-lactamase (VIM),* Corresponding author. Tel.: +39 051 6364316; fax: +39 051 6363076.
E-mail address: paolo.gaibani@unibo.it (P. Gaibani).
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carbapenemases have represented the most common ﬁndings,
while more recently class D oxacillinase-48 (OXA-48) has
emerged.1 In particular, Italy and Greece have reported a great
spread of KPC and metallo-b-lactamases (MBL), mostly of VIM
and NDM.1–6
Carbapenemase-producers are mainly identiﬁed among Kleb-
siella pneumoniae and Escherichia coli, while for other Enterobac-
teriaceae this type of resistance is still relatively uncommon.1Only
a few studies have reported Citrobacter freundii harboring MBL or
KPC carbapenemases, most of them carrying blaVIM or blaKPC
genes.5–7 Moreover, the isolation of a VIM-producing C. freundii is
still rare in Europe.6,7 Up until today, only one study has reported
the ﬁnding of an MBL-producing C. freundii isolate in Italy.8 Here,
we describe an outbreak of blaVIM-1-producing C. freundii isolated
from rectal swabs of colonized patients hospitalized in an Italian
hospital.ses. Published by Elsevier Ltd. All rights reserved.
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2.1. Antimicrobial susceptibility testing and molecular analysis of C.
freundii isolates
From June 1 to June 15, 2012, eight isolates of C. freundii were
isolated from rectal swabs of patients hospitalized on a medical
ward of a hospital located in the Bologna metropolitan area as a
result of active screening following the detection of a KPC-positive
patient on the same ward. Each C. freundii strain was isolated using
a chromogenic selective medium (Brilliance CRE, Oxoid, UK).
Routine biochemical identiﬁcation and antimicrobial susceptibili-
ty testing were carried out using the Vitek2 semi-automated
system (bioMe´rieux, France). Minimum inhibitory concentration
(MIC) results were interpreted according to the European
Committee on Antimicrobial Susceptibility Testing (EUCAST)
guidelines.9 Carbapenem MIC values were conﬁrmed by E-test.
C. freundii isolates were further tested by a disk-diffusion synergy
test as conﬁrmatory/discriminatory carbapenemase phenotypic
assay.10 A PCR assay for bla genes, including VIM, IMP, GIM, SIM, and
SPM was performed in order to identify the speciﬁc MBL gene, and
the amplicons obtained were analyzed in order to identify the
speciﬁc bla gene.11,12 Results were compared and aligned with
reference sequences using the online BLAST database and CLUSTAL
W software.
2.2. Multilocus sequence typing (MLST)
To determine the genetic relationships between the C. freundii
isolates, MLST based on seven housekeeping genes (aspC, clpX,
fadD, mdh, arcA, dnaG, lypS) was performed, as described
previously.13
2.3. Cluster management and infection control
In July 2011, the health agency of the Emilia-Romagna region
issued a speciﬁc surveillance protocol in order to improve the
prevention and control of CPE.14 The implementation of the
regional guidelines by local hospitals requires extended infection
control measures, including: isolation or cohorting of colonized/
infected patients; strict contact precautions and reinforced handTable 1
Results of antimicrobial susceptibility testing of VIM-1-producing Citrobacter freundii s
No. of isolate Patient sex and age,
sample collection date
(day/month/year)
Antimicrobial
AMC TZP CTX CAZ 
CF1 F, 90
(01/06/12)
32
R
128
R
64
R
64
R
CF2 M, 87
(01/06/12)
32
R
128
R
64
R
64
R
CF3 F, 93
(01/06/12)
32
R
128
R
64
R
64
R
CF4 F, 74
(01/06/12)
32
R
128
R
64
R
64
R
CF5 M, 97
(08/06/12)
32
R
128
R
64
R
64
R
CF6 F, 83
(08/06/12)
32
R
128
R
64
R
64
R
CF7 M, 76
(15/06/12)
32
R
128
R
64
R
64
R
CF8 M, 74
(15/06/12)
32
R
128
R
64
R
64
R
MIC, minimum inhibitory concentration; EUCAST, European Committee on Antimicr
tazobactam; CTX, cefotaxime; CAZ, ceftazidime; ERT, ertapenem; IPM, imipenem; MEM, m
colistin; SXT, trimethoprim–sulfamethoxazole.
a Interpretation: S = susceptible; I = intermediate; R = resistant.hygiene; active surveillance by rectal swab cultures; screening of
contact patients (when a positive case is detected); and, for
patients with higher clinical and/or epidemiological risks, culture
screening upon admission to the hospital.
3. Results
From June 1 to 15, 2012, eight C. freundii isolates were recovered
from specimens of colonized patients. The isolates were resistant
to all b-lactams, b-lactam/b-lactamase inhibitor combinations,
and imipenem, while still susceptible to ciproﬂoxacin, colistin,
tigecycline, trimethoprim–sulfamethoxazole, meropenem, and
ertapenem (Table 1). The synergy test gave positive results for
the meropenem disk in association with dipicolinic acid for all
eight strains, suggesting the production of MBL. PCR analysis and
nucleotide sequencing revealed that all these isolates carried
the blaVIM gene. Sequence analysis of the eight cloned amplicons
performed with BLAST software showed 100% homology with the
blaVIM-1 sequences available in GenBank.
The MLST assay revealed that all the C. freundii strains had
identical allele proﬁles. Comparison of the seven housekeeping
genes obtained from a previously described human C. freundii
isolate in China revealed several nucleotide substitutions among
the seven housekeeping genes (data not shown). In particular, the
highest variability was identiﬁed in the fadD gene (which is known
to be the most variable among these seven genes). In order to
evaluate the genetic relatedness of these C. freundii strains with
previously reported isolates, we inferred an evolutionary relation-
ship by constructing a neighbor-joining tree using a concatenated
sequence of the seven housekeeping genes obtained from different
human C. freundii isolates, as shown in Figure 1. The tree showed
strict clustering of the Italian C. freundii isolates with the ST5
isolated in China from a patient suffering from acute diarrhea.13
On June 1, 2012, the local infection control committee of one of
the hospitals located in the Bologna metropolitan area, received
information about the isolation of a KPC-positive K. pneumoniae
strain from a patient who was hospitalized on a medical ward. The
committee correctly suggested that the affected ward apply active
surveillance for all potential contact patients. As a consequence, 42
rectal swabs were taken within 1 day. This screening activity
showed the detection of four patients colonized with a VIM-trains: MIC values (mg/l) and EUCAST susceptibility interpretationa
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obial Susceptibility Testing; AMC, amoxicillin–clavulanic acid; TZP, piperacillin–
eropenem; AK, amikacin; GM, gentamicin; CIP, ciproﬂoxacin; TIG, tigecycline; COL,
Figure 1. Genetic relationships among Citrobacter freundii strains isolated from patients in Italy and in China,13 as indicated by multilocus sequence typing data. The
phylogenetic tree was inferred using the neighbor-joining (NJ) method based on the aligned concatenated sequences of the seven housekeeping genes obtained from the
different sequence types (ST) and Citrobacter rodentium (used as the outgroup).
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found. During the following 2 weeks, four other patients from the
same ward had a positive result for C. freundii, showing an identical
phenotype. No clinically relevant isolates of these microorganisms
were found among the patients hospitalized on the affected ward.
Even though a detailed epidemiological investigation was per-
formed, the evaluation of collected data did not permit the
identiﬁcation of the potential index case.
The cluster of colonized patients was managed by applying the
measures suggested by the regional protocol: infection control
operators visited the ward to investigate any incorrect care
behavior and meetings to refresh and improve staff training were
organized; all the colonized patients were subjected to cohorting
to ensure the strict application of contact precautions; microbio-
logical screening was performed to monitor the transmission of
CPE to other patients. This early and intensive action allowed
containment of the cluster and no more cases were detected
starting from June 16, 2012. The screening activity was continued
for an additional 4 weeks, and no more C. freundii bearing blaVIM-1
were identiﬁed.
4. Discussion
The global spread of Enterobacteriaceae carrying plasmid-
mediated carbapenem resistance has been observed worldwide,
but since 2010 the increase in these MDR organisms has been very
rapid, especially in Europe.1 Based on previous reports, the
epidemiology of Enterobacteriaceae harboring different carbape-
nemase types, such as NDM and KPC, suggests a condition of
endemicity in the Italian area.1–4 Among the different carbapene-
mase-producing Enterobacteriaceae, the most common species is K.
pneumoniae, followed by E. coli, while various others species have
been isolated sporadically both from infected and colonized
patients.1 In particular, few studies have reported on the isolationof C. freundii strains carrying carbapenemase genes.5,6,8 This study
reports an outbreak of VIM-producing C. freundii in an Italian
hospital. MLST analysis grouped all these eight C. freundii isolates
in a close relationship with the ST5 strain recently reported from a
diarrhea patient in China.13
The rapid identiﬁcation of patients colonized and infected
with CPE is recognized as a basic tool to control and prevent the
global spread of these MDR pathogens.1 In our study, we showed
that active surveillance performed by rectal swab culture
screening of all the potential contacts is useful, not only to
control inter-patient transmission of a previously known MDR
strain, but also to detect additional colonization with other types
of CPE with the potential to spread among hospitalized patients.
This approach thus represents an efﬁcient measure to minimize
the risk of nosocomial outbreaks caused by carbapenemase
producers. The accurate and rapid identiﬁcation of VIM-produc-
ing C. freundii strains allowed the infection control team to
rapidly detect a cluster of patients colonized with this unusual
type of CPE. This quick identiﬁcation allowed the medical ward to
contain the dissemination of these MDR bacteria among the
hospitalized patients. It is noteworthy that despite the unfavor-
able clinical features of most patients (mean age >84 years, many
comorbidities), colonization had not given rise to any clinically
signiﬁcant infection. This favorable clinical outcome could be due
to several factors, possibly including low bacterial loads and mild
pathogenic capacities of the colonizing germs. In addition, it is
not yet clear if certain types of CPE and/or certain types of
carbapenemase could have a higher pathogenicity than others.
Nevertheless the observation that none of the eight patients
colonized by VIM-producing C. freundii had signs of clinical
infection related to this MDR organism should not lead to the
underestimation of the value of active surveillance measures,
because any further spread to other patients might have resulted
in more serious clinical effects.
P. Gaibani et al. / International Journal of Infectious Diseases 17 (2013) e714–e717 e717In conclusion, our data conﬁrm that in order to contain and
control the spread of carbapenem-resistant Enterobacteriaceae, it is
necessary to maintain and enforce all the infection control
measures, among which a pivotal role is played by microbiological
screening of potentially colonized patients.
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